Skip to main content
If you continue browsing this website, you agree to our policies:
  • Politique de confidentialité
Continue
x
eCampus
  • Home
  • Outils
    Portfolio Mahara Wooclap
  • Tutoriels
    bientôt disponible !
  • More
English ‎(en)‎
English ‎(en)‎ Español - Internacional ‎(es)‎ Français ‎(fr)‎
You are currently using guest access
Log in
eCampus
Home Outils Collapse Expand
Portfolio Mahara Wooclap
Tutoriels Collapse Expand
bientôt disponible !
Expand all Collapse all
  1. Dashboard
  2. M1 D2HP 24-25
  3. TU 08: Biotechnology (S1)
  4. Lectures

Lectures

Completion requirements
    • BIOBETTER - QC biopharmaceuticals and case study- MT BIOBETTER - QC biopharmaceuticals and case study- MT
      • Biobetters-M1 internat- 2024 -TAVERNA-without corrections.pdf Biobetters-M1 internat- 2024 -TAVERNA-without corrections.pdf
      • Case study TUO8-Biotech 2024-from gene, production QC, formulation to biobetters-MT EPO-7 Nov 2024.pdf Case study TUO8-Biotech 2024-from gene, production QC, formulation to biobetters-MT EPO-7 Nov 2024.pdf
      • QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf
    • Biodrugs M1 D2HP 2024.pdf Biodrugs M1 D2HP 2024.pdf
    • D2HP biotech intro FFAY 2024-25.pdf D2HP biotech intro FFAY 2024-25.pdf
    • ffay Lecture gene therapy non viral vectors D2HP 2024-25.pdf ffay Lecture gene therapy non viral vectors D2HP 2024-25.pdf
    • ffay Lecture oligonuceloitide D2HP 2024-25.pdf ffay Lecture oligonuceloitide D2HP 2024-25.pdf
    • Vaccine production 24 25.pdf Vaccine production 24 25.pdf
◄ documents
Cell therapy introduction ►
You are currently using guest access (Log in)
Policies
Get the mobile app
Powered by Moodle

eCampus

Université Paris-Saclay 7
  • UPSaclay
  • UEVE
  • UVSQ
  • Centrale Supélec
  • École Normale Supérieure
  • Institut d'Optique
  • AgroParisTech
Institut Polytechnique de Paris 3
  • ENSTA
  • Télécom Paris

European University Alliance for Global Health (EUGLOH)
  •  


Nouveautés